Nedocromil calcium and use thereof in treatment of reversible obstructive airways disease
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 18, 1989
Grant Date -
N/A
app pub date -
Feb 24, 1988
filing date -
Feb 28, 1987
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
There are described a new compound, methods for its preparation and compositions containing it. Calcium 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano[3,2-g]-quinoline-2,8-dicarboxylate is a novel compound and is useful in the treatment of reversible obstructive airways disease and/or the prevention or treatment of rhinitis.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully